Specialized Biotech Focus Human Predictions operates within the biotechnology research industry, offering tailored consulting services in pharmacometrics and clinical pharmacology. This specialization suggests an opportunity to target pharmaceutical and biotech companies seeking advanced data integration and clinical development support.

Recent Funding Success The company successfully raised approximately 1 million dollars in 2019 from prominent investors, indicating strong investor confidence. This financial backing can be leveraged to promote advanced solutions or expand service offerings to similar organizations.

Potential Market Niche With a small team of 11 to 50 employees, Human Predictions likely focuses on high-value, specialized projects for clients in drug development and clinical research, presenting an opportunity to approach similar niche biotech and pharma firms with tailored consulting packages.

Technology Stack Leverage Utilizing common industry tools such as SQL, WordPress, and Microsoft 365, Human Predictions demonstrates readiness for data-driven solutions. Offering complementary data management or analytics services could appeal to their needs for efficient data integration and novel analysis.

Growth Opportunities Given their focus on integrating diverse data sources to increase knowledge precision, there is potential to position software or solutions aimed at enhancing data analysis capabilities, automation, or decision-making efficiency for clients in clinical research and drug development.